ACTBL2 as a binding partner of gelsolin (GSN) (Mazur et al., 2016), has also been attributed to increasing cell proliferation in human colorectal adenocarcinoma and melanoma cells (Litwin et al., 2012). Here, GSN is linked to melanoma.